[
  {
    "ts": null,
    "headline": "PNC Financial Services Fourth-Quarter Results Top Street Views",
    "summary": "PNC Financial Services (PNC) reported fourth-quarter results above Wall Street's estimates on Friday",
    "url": "https://finnhub.io/api/news?id=5408fb093451072994a13fc70c2daa1b9a8d00381ffd2d916b131f092bf05d9a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768572580,
      "headline": "PNC Financial Services Fourth-Quarter Results Top Street Views",
      "id": 138152669,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "FDS",
      "source": "Yahoo",
      "summary": "PNC Financial Services (PNC) reported fourth-quarter results above Wall Street's estimates on Friday",
      "url": "https://finnhub.io/api/news?id=5408fb093451072994a13fc70c2daa1b9a8d00381ffd2d916b131f092bf05d9a"
    }
  },
  {
    "ts": null,
    "headline": "State Street Profit Falls as Expenses Jump",
    "summary": "State Street logged lower profit in the fourth quarter, despite achieving what it called record revenue, as expenses jumped.",
    "url": "https://finnhub.io/api/news?id=79e7c19cd663dbd79db916d98a36641ee02d55ba62105cb69acd007de48de676",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768571460,
      "headline": "State Street Profit Falls as Expenses Jump",
      "id": 138152745,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "FDS",
      "source": "Yahoo",
      "summary": "State Street logged lower profit in the fourth quarter, despite achieving what it called record revenue, as expenses jumped.",
      "url": "https://finnhub.io/api/news?id=79e7c19cd663dbd79db916d98a36641ee02d55ba62105cb69acd007de48de676"
    }
  },
  {
    "ts": null,
    "headline": "PNC Profit Rises as Loans Increase",
    "summary": "PNC posted higher fourth-quarter profit on the back of loan growth and increased demand for its financial services.",
    "url": "https://finnhub.io/api/news?id=ddeeef22f672fdf0d75884310f6ec57a445ca1ce3b7bdbd0b5e99bdfea079b33",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768565160,
      "headline": "PNC Profit Rises as Loans Increase",
      "id": 138151910,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "FDS",
      "source": "Yahoo",
      "summary": "PNC posted higher fourth-quarter profit on the back of loan growth and increased demand for its financial services.",
      "url": "https://finnhub.io/api/news?id=ddeeef22f672fdf0d75884310f6ec57a445ca1ce3b7bdbd0b5e99bdfea079b33"
    }
  },
  {
    "ts": null,
    "headline": "M&T Bank Profit Rises on Higher Net Interest Income",
    "summary": "M&T Bank posted higher fourth-quarter profit, boosted by growth in its net interest income and net interest margin.",
    "url": "https://finnhub.io/api/news?id=ff9ff8a464a9cfacb5646c2801f35eba3cc8fc0ea80e380b785a6e6138ee0272",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768564020,
      "headline": "M&T Bank Profit Rises on Higher Net Interest Income",
      "id": 138151853,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "FDS",
      "source": "Yahoo",
      "summary": "M&T Bank posted higher fourth-quarter profit, boosted by growth in its net interest income and net interest margin.",
      "url": "https://finnhub.io/api/news?id=ff9ff8a464a9cfacb5646c2801f35eba3cc8fc0ea80e380b785a6e6138ee0272"
    }
  },
  {
    "ts": null,
    "headline": "This Biotech Stock Is Up 100% This Year. Why It’s Soaring Again Today.",
    "summary": "ImmunityBio  stock is on a tear in 2026 and it looks like the biotech company’s stellar rally will keep going.  The biotech company said full-year revenue from its bladder cancer drug ANKTIVA was set to surge 700% year-over-year to $113 million, in its preliminary earnings results Thursday.  Earlier this week Immunitybio said the Saudi Food and Drug Authority has approved ANKTIVA for the treatment of patients with non-small cell lung cancer.",
    "url": "https://finnhub.io/api/news?id=df3815604a2c4d9635790474fd92ac4fbe3d36c1927e501042769f56938c34f3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768560720,
      "headline": "This Biotech Stock Is Up 100% This Year. Why It’s Soaring Again Today.",
      "id": 138151912,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "FDS",
      "source": "Yahoo",
      "summary": "ImmunityBio  stock is on a tear in 2026 and it looks like the biotech company’s stellar rally will keep going.  The biotech company said full-year revenue from its bladder cancer drug ANKTIVA was set to surge 700% year-over-year to $113 million, in its preliminary earnings results Thursday.  Earlier this week Immunitybio said the Saudi Food and Drug Authority has approved ANKTIVA for the treatment of patients with non-small cell lung cancer.",
      "url": "https://finnhub.io/api/news?id=df3815604a2c4d9635790474fd92ac4fbe3d36c1927e501042769f56938c34f3"
    }
  }
]